PRESS RELEASE
News
-
-
-
PRESS RELEASE
Commerce Resources and Mont Royal Resources Enter Into Arrangement Agreement to Create a Canadian-Focused Critical Minerals Development Company
Commerce Resources Corp. and Mont Royal Resources Limited announce merger agreement to create dual-listed critical minerals explorer. Transaction value, rationale, and key details outlined -
-
PRESS RELEASE
Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
Aspire initiates Phase 1 trial for high-dose aspirin formulation to target acute myocardial infarction. Trial to evaluate safety, pharmacokinetics, pharmacodynamics, with fast track FDA application -
-
-
PRESS RELEASE
Immunic, Inc. Announces Pricing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
Immunic, Inc. announces pricing of $5.1 million registered direct offering led by Aberdeen Investments for clinical pipeline of therapies. Funds to be used for clinical trials and operations -
PRESS RELEASE
Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris
Bausch Health Canada signs agreement with pCPA for PrCABTREO gel to be covered by Canadian public drug plans. CABTREO is a triple-combination topical treatment for acne vulgaris -
